Noxxon CEO Talks Partnering Strategy & Cancer Combos
Executive Summary
Aram Mangasarian, CEO of Noxxon Pharma, a biotech company focused on cancer therapies targeting the tumor microenvironment, discusses partnering options and his strategy for how Noxxon can compete in the busy immuno-oncology space.